[ad_1] A case of solar maculopathy from the retina specialist’s perspective. Note the permanent injury to the central macula in the images, which causes central blind spots… http://imagebank.asrs.org/case/2183/solar-maculopathy Solar Maculopathy – Retina Image Bank A 50 year old woman was referred for evaluation of a …
[ad_1] Just presented at the annual meeting of the American Society of Retina Specialists… Real-World Anti-VEGF Results Fall Short in Macular Edema Anti-vascular endothelial growth factor treatments do not work as well in the clinic as they do in trials for diabetic macular edema, but …
[ad_1]
Just published Retina Insider article on interpreting clinical trials in macular degeneration and diabetic macular edema:
http://www.reviewofophthalmology.com/article/how-to-interpret-clinical-trial-outcomes
How to Interpret Clinical Trial Outcomes
Thomas A. Ciulla, MD, MBA, Indianapolis Published 8 August 2017 How to Interpret Clinical Trial Outcomes Making sense of primary and secondary endpoint outcomes in macular degeneration and diabetic macular edema trials. Given an increasing amount of physician participation and reliance on randomized…
[ad_2]
Return to main website.
[ad_1] Thomas A. Ciulla, M.D. updated their profile picture. [ad_2] Return to main website.
[ad_1] A review we just published on Emerging Anti-VEGF Agents for Neovascular AMD… http://www.tandfonline.com/eprint/KbY55Gyay3kpEMxMDmuQ/full Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration (2017). Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration. Expert Opinion on Emerging Drugs. Ahead …
[ad_1]
Our study published in the journal, Retina: Lean Six Sigma to improve patient care, satisfaction & minimize waste…
Physician MBAs and faculty publish research on improving clinic wait times in prominent journal.
[ad_2]
Return to main website.